Video

Dr. Favret on Extending Survival and Improving Outcomes in Breast Cancer

Author(s):

Anne Favret, MD, discusses the importance of clinical trials in the breast cancer space.

Anne Favret, MD, medical oncologist and co-director of Breast Research at Virginia Cancer Specialists, discusses the importance of clinical trials in the breast cancer space.

Breast cancer treatment is a marathon, not a sprint, says Favret. Often, women with breast cancer will live for a long time and so regimens that help maintain best quality of life and also extend life are necessary; this is always a challenge, adds Favret. Additionally, being able to recognize new data and incorporate that information into new trials can help to extend the methods that are available for use; that is clinically very important, concludes Favret.

Related Videos
Sundar Jagannath, MBBS
Kevin Kalinsky, MD, MS,
Aaron Gerds, MD
Paolo Tarantino, MD
Chinmay Jani, MD, clinical fellow, Hematology & Oncology, Sylvester Comprehensive Cancer Center at the University of Miami/Jackson Memorial Hospital
Shella Saint Fleur-Lominy, MD, PhD
Benjamin Levy, MD
Nader Sanai, MD, chief, Neurosurgical Oncology, director, Ivy Brain Tumor Center, Barrow Neurological Institute
Manali Kamdar, MD
Ibrahim Aldoss, MD